Single Palatal Temporary Anchorage Device for Anterior Open Bite (SPaTAR)

April 15, 2026 updated by: Peter Mossey, University of Dundee

Single Palatal Temporary Anchorage Device for Anterior Open Bite: a Randomized Clinical Trial

Participants are orthodontic patients with anterior open bite (AOB) malocclusion. These patients will be treated by molar intrusion achieved using one of two interventions, either orthodontic fixed appliances incorporating a single palatal Temporary Anchorage Device (TAD) or orthodontic fixed appliances incorporating two buccal TADs

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Participants will be recruited from those attending Dundee Dental Hospital Orthodontic Department and those currently awaiting treatment. Those that meet the inclusion and exclusion criteria will be invited to participate. After obtaining consent they will be allocated to receive one of the two interventions. The two interventions represent the currently available options for treatment of mild - moderate (1-6mm) anterior open bite in the Orthodontic Department and as such patients will be receiving routine treatment regardless of the arm they are randomised to. In order to assess the more effective intervention additional records will be taken during the treatment involving additional cephalometric radiographs, additional intra-oral scans or dental impressions (See later for details). Primary outcome is at the end of intrusion with TADs after 9-12 months, but participants will be followed until completion of treatment for the secondary outcome of stability of intrusion and overbite correction

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dundee, United Kingdom, DD1 4HR
        • Dundee Dental Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with AOB of 1-6mm
  • Aged between (12 and 40 years).
  • Able to consent.
  • Patient due to undergo orthodontic treatment with fixed orthodontic braces.

Exclusion Criteria:

  • Patient has previously had upper first permanent molar extraction.
  • Patient with congenital cleft of lip and/or palate or any other craniofacial anomalies.
  • Patient with bone disease or taking medications that affect the bone quality or nature.
  • Patient with an active digit sucking habit.
  • Pregnant or breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single Palatal TAD
Single Palatal TAD for orthodontic molar intrusion
A single mini-screw inserted in the mid-palate
Experimental: Two buccal TADs
Two buccal TADs for orthodontic molar intrusion
Two buccal TADs inserted in the upper jaw

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Molar intrusion
Time Frame: 9-12 months after treatment commences
Amount of upper molar intrusion measured in mms on cephalometric radiograph
9-12 months after treatment commences

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overbite (vertical overlap of anterior teeth)
Time Frame: 9-12 months after treatment commences
Change in overbite (vertical overlap of anterior teeth) measured clinically directly from the teeth with a ruler and on 3D dental scans using 3D analysis software, both in mms
9-12 months after treatment commences
Patient Experience
Time Frame: 9-12 months after treatment commences
Patient experience with the use of temporary anchorage devices for intrusion by validated questionnaire which uses 3 or 4 point Likert Scales for a range of questions across relevant doamins. Depending on the question the scales are 'Improved/Same/Worse/Much worse' or 'Not at all / A little / A lot' or 'I do more / no difference / I do less' (Yassir et al 2017)
9-12 months after treatment commences

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Mossey, BDS, University of Dundee

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

May 29, 2020

First Submitted That Met QC Criteria

June 4, 2020

First Posted (Actual)

June 5, 2020

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 15, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2-054-19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Openbite

Clinical Trials on Single Palatal TAD

Subscribe